SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (2653)5/4/2011 6:12:08 PM
From: former_pgs  Respond to of 3202
 
>Found a low affinity MAb, and you can imagine how that impressed me.<

It might be useful one day if we find that there is a therapeutic effect to binding albumin* ;-)

* for those who haven't spent unnecessarily extensive time in the lab, lower affinity antibodies will have an increased tendency to cross-react with other abundant proteins through simple mass action. Albumin is one of the most abundant in the serum.